FDA Authorizes AI Platform for Breast Cancer Prediction
The FDA grants De Novo authorization for a new device for future five-year breast cancer risk prediction, based on an image alone.
The FDA grants De Novo authorization for a new device for future five-year breast cancer risk prediction, based on an image alone.
The agencies are asking stakeholders to weigh in on a sweeping deregulatory initiative that will eliminate 10 regulations for every one introduced.
Kettering Health is investigating a cybersecurity incident that disrupted its systems.
UCLA Health is the first in the US to integrate Siemens’ mobile head CT scanner for on-scene stroke diagnosis.